Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

XOMA Corporation (XOMA)

-NasdaqGM
3.73 Down 0.03(0.67%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:3.75
Open:3.75
Bid:3.70 x 1000
Ask:4.02 x 300
1y Target Est:9.17
Beta:3.88
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:3.69 - 3.79
52wk Range:2.92 - 5.95
Volume:2,038,461
Avg Vol (3m):2,441,650
Market Cap:438.86M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
XOMADown 0.67%438.86M
NVSUp 1.30%241.55B
REGNUp 0.90%53.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):24.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback